ENDP - Endo files for Chapter 11 bankruptcy; in restructuring support agreement with creditors
- Endo International ( NASDAQ: ENDP ) has filed for Chapter 11 bankruptcy in New York as part of a restructuring support agreement (RSA) with the pharma company's first lien debt holders.
- Earlier Tuesday, Bloomberg reported that creditors were looking at putting Endo ( ENDP ) up for sale through a bankruptcy proceeding.
- The RSA involves more than a majority of the first lien debt holders.
- The debtholder group has agreed to provide purchase consideration of ~$6B through a credit bid, as well as assuming some liabilities, for nearly all of Endo's ( ENDP ) assets.
- Endo ( ENDP ) noted that the "stalking horse" biud is subject to higher or better offers.
- The company has been plagued by more than $8B of debt as well as ongoing litigation related to its alleged role in the nation's opioid crisis .
For further details see:
Endo files for Chapter 11 bankruptcy; in restructuring support agreement with creditors